your market intelligence analyst
Search Results
280 results
Your search is now limited to «Johnson & Johnson» expert search.
Ohio's attorney general said an investigation found J&J, the world's biggest health products maker, violated state consumer protection laws by not fully disclosing the devices' risks.
More from Minneapolis Star-Tribune (United States):
TRENTON, N.J. (AP) — Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women’s sagging pelvic organs. Ohio’s attorney general said an investigation found J&J, the world’s biggest health products maker, violated state consumer protection laws by not fully disclosing the devices’ […]
FiercePharmaManufacturing 10/17/2019 09:43
The Institute for Clinical and Economic Review (ICER) unveiled its final evidence report on J&J’s Xarelto and Amarin’s Vascepa, finding both drugs hit the group’s cost-effectiveness standards when used as add-on treatments for CV disease.
More from FiercePharmaManufacturing:
PMLiVE 10/17/2019 06:39
As well as J&J, opioid medication distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health have also offered to pay $18bn in cash over 18 years, according to Reuters.
More from PMLiVE:
Claims Journal 10/16/2019 12:22
Tobias said an Oklahoma judge’s decision to hit J&J with $572 million in damages over its sales of opioid painkillers in that state may have sent J&J an unmistakable signal.
More from Claims Journal:
24/7 Wall Street 10/16/2019 08:45
Wednesday's top analyst upgrades, downgrades and initiations included Adobe, Alibaba,, AT&T, Comcast, Delphi Technologies, DocuSign, Johnson & Johnson, JPMorgan, T-Mobile, Verizon...
More from 24/7 Wall Street: 10/15/2019 19:14
Oklahoma judge admits to $107 million 'error' in J&J opioid case.
More from
Traders on Tuesday turned their attention to third-quarter earnings and hopes for an interest rate cut by the Federal Reserve at the end of the month. The Dow Jones Industrial Average opened 118 points higher at 26,905, while the Nasdaq added 37 points to 8,085 and S&P 500 gained 12 points to 2,978. Investors pushed aside worries about U.S.-China trade negotiations and political turmoil in Washington to take their cues from corporate America as earnings season kicked into gear.
ETHealthWorld (India) 10/15/2019 07:35
J&J on Tuesday said it now expects full-year adjusted earnings per share in the range $8.62 to $8.67, from its prior forecast of $8.53 to $8.63.
More from ETHealthWorld (India):
CNBC - Business 10/15/2019 06:47
J&J's pharmaceutical business, which accounts for half of the company's revenue, posted revenue of $10.88 billion, better than the $10.41 billion projection compiled by StreetAccount.
More from CNBC - Business: 10/15/2019 00:32
Just last week, a jury ordered J&J to pay $8 billion for wrongfully pushing doctors to prescribe the anti-psychotic drug Risperdal.
More from
Top Class Actions 10/14/2019 16:22
A federal judge says he will likely approve a $6.3 million settlement deal which would end class action claims that Johnson & Johnson falsely advertise their Infants’ Tylenol as being substantially different from their... .
More from Top Class Actions:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications